FDA Approves Nausea Prevention Drug

The FDA has approved a new oral formulation of ALOXI(R) (palonosetron hydrochloride) made by Eisai Corporation of North America and its partner Helsinn Healthcare SA for the prevention of chemotherapy-induced nausea and vomiting (CINV) (Medical News Today, Aug. 24).

Latest posts by admin aapc (see all)

Comments are closed.

Have you used AAPC's member discount savings program (e.g., travel, entertainment)? (On top menu: Resources/Other Resources/Savings Center)